Tirzepatide is now the most prescribed anti-diabetic (ADM) and anti-obesity (AOM) medication (sold as Mounjaro and Zepbound, respectively)
GLP-1 medications suppress appetite, which means you're consuming less of the dietary fat needed for fat-soluble vitamin absorption and fewer overall nutrients
However, its essential to remember that sustainable weight loss requires long-term lifestyle changes, whether or not you continue the medication
[10] Sappington, D.R., Siegel, E.R., Hiatt, G., Desai, A., Penney, R.B., Jamshidi-Parsian, A
The efficacy and tolerability of liraglutide (daily s/c GLP1a) have been reported elsewhere [79] and have been shown to improve weight loss outcomes in that where satisfactory weight loss following surgery has not been achieved [10]